An £835k donation to a hospital enables surgeons to use the new technology.

The Stealth AXiS system architecture allows support for a variety of surgeon preferences and clinical complexities.

Medtronic (NYSE:MDT) announced today that it received FDA clearance for its Stealth AXiS robotic system for spine surgery.

The robot, named Hugo, is being used at the Queen Elizabeth the Queen Mother Hospital in Margate.

Dr. Homoud Aldahash sat three meters away from his patient as he removed a brain tumor via a robot.

FDA’s clearance of Medtronic’s Stealth Axis surgical system comes on the heels of the company winning a nod for the Hugo ...

When James Choate-Deeds was diagnosed with prostate cancer, he joined a clinical trial for robotic-assisted surgery ...

Patients needing spine surgery at Augusta Health now have access to advanced robotic technology that enhances accuracy and ...

Technological innovation is redefining the very nature and impact of robotic surgery. As the sector races toward a $50 billion valuation by 2032, I believe we must look beyond the market cap to ...

Robotics technology is quickly disrupting a variety of sectors, including the medical space, and surgical robot applications are a major component of the overall medical robots market. In fact, a ...

Scarless robotic thyroid surgery is now available in Georgia as American Endocrine expands access to advanced minimally ...

In Saskatchewan, new robot-assisted surgical units are popping up in some of the province's biggest hospitals, helping to ...